HuGE Literature Finder
Records
1
-
30
| Polymorphisms of matrix metalloproteinases affect the susceptibility of esophageal cancer: Evidence from 20412 subjects, systematic review and updated meta-analysis. Medicine 2021 Sep 100 (38): e27229. Chen Hai, Xu Xianquan, Hua Congshu, Zhang Heng, Jian Junling, Ge Tengfei, Xie Jianfeng, Yu Zaiche |
| Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer. Molecular biology reports 2020 Nov . Balkhi Sahar, Mashayekhi Farhad, Salehzadeh Ali, Saedi Hamid Saee |
| Association of matrix metalloproteinases 3 and 9 single nucleotide polymorphisms with breast cancer risk: A case-control study. Molecular and clinical oncology 2020 Jul 13 (1): 54-62. Abd Elmaogoud Ragab Ibrahim Fawziya, Essam Elfeky Shaymaa, Haroun Medhat, Abd Elrahman Ahmed Mohamed, Elnaggar Mostafa, Abd Elfatah Ismail Nada, Ahmed Abd El Moneim Nad |
| Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis. Journal of thoracic disease 2020 Mar 12 (3): 349-362. Li Xiaoliang, Liu Caiyang, Ran Ran, Liu Gaohua, Yang Yanhui, Zhao Wenzhuo, Xie Xiaoyang, Li |
| Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review. Cancer management and research 2018 10 5247-5259. Zhou Hongxing, Zhu Xumi |
| Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma. Oncotarget 2017 Dec 8 (62): 105971-105983. Lin Youdong, Liu Jinsheng, Jin Long, Jiang Y |
| Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review. PloS one 2017 12 (9): e0185456. Zhu Xu-Ming, Sun Wei-Fe |
| Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer. PloS one 2017 12 (9): e0184448. Padala Chiranjeevi, Tupurani Mohini Aiyengar, Puranam Kaushik, Gantala Srilatha, Shyamala Nivas, Kondapalli Mrudula Spurthi, Gundapaneni Kishore Kumar, Mudigonda Saraswati, Galimudi Rajesh Kumar, Kupsal Keerthi, Nanchari Santoshi Rani, Chavan Uday, Chinta Sanjeeva Kumari, Mukta Srinivasulu, Satti Vishnupriya, Hanumanth Surekha Ra |
| Single nucleotide polymorphisms as markers of genetic susceptibility for oral potentially malignant disorders risk: Review of evidence to date. Oral oncology 2016 Oct 61 146-51. Shridhar Krithiga, Aggarwal Aastha, Walia Gagandeep Kaur, Gulati Smriti, Geetha A V, Prabhakaran D, Dhillon Preet K, Rajaraman Preet |
| MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. Genetic testing and molecular biomarkers 2015 Aug . Tao Liu, Li Zuo, Lin Li, Lei Yin, Hongyuan Yu, Hongwei Jing, Yang Liu, Chuize Ko |
| Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Apr 21 (7): 1583-90. Bohanes Pierre, Rankin Cathryn J, Blanke Charles D, Winder Thomas, Ulrich Cornelia M, Smalley Stephen R, Rich Tyvin A, Martensen James A, Benson Al B, Mayer Robert J, Cripps Christine M, Danenberg Kathleen, Makar Karen W, Zhang Wu, Benedetti Jacqueline K, Lenz Heinz-Jos |
| DLX1 and MMP3 contribute to oral clefts with and without positive family history of cancer. Archives of oral biology 2015 Feb 60 (2): 223-8. Sabóia Ticiana M, Reis Maria Fernanda, Martins Ângela M C, Romanos Helena F, Tannure Patricia N, Granjeiro José Mauro, Vieira Alexandre R, Antunes Leonardo S, Küchler Erika C, Costa Marcelo |
| Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study. Biotechnology, biotechnological equipment 2014 Sep 28 (5): 904-910. Vlaykova Tatyana, Kurzawski Mateusz, Tacheva Tanya, Dimov Dimo, Gulubova Maya, Yovchev Yovcho, Chakarov Stoyan, Drozdzik Mar |
| Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies. PloS one 2014 9 (1): e87562. Yang Xin, Hu Jing-Wen, Qiu Man-Tang, Li Ming, Yin Rong, Wang Jie, Xu Lin, Zhang Q |
| Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects. Annals of agricultural and environmental medicine : AAEM 2014 21 (3): 546-51. Brzóska Kamil, Bart?omiejczyk Teresa, Sochanowicz Barbara, Cymerman Magdalena, Grudny Jacek, Ko?akowski Jacek, Kapka-Skrzypczak Lucyna, Kruszewski Marcin, Sliwi?ski Pawe?, Roszkowski-?li? Kazimie |
| Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. Journal of cancer research and clinical oncology 2013 Sep 139 (9): 1433-47. Li Xiaoying, Qu Lianxi, Zhong Yu, Zhao Yingjie, Chen Hongyan, Daru |
| Association of genetic dependences between lung cancer and chronic obstructive pulmonary disease. Pneumonologia i alergologia polska 2013 81 (4): 4. Grudny J, Ko?akowski J, Kruszewski M, Szopi?ski J, Sliwi?ski P, Wiatr E, Winek J, Za??ska J, Zych J, Roszkowski-?li? K |
| Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Gene 2013 Jan . Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J |
| Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PloS one 2013 8 (5): e63165. Slattery Martha L, John Esther, Torres-Mejia Gabriela, Stern Mariana, Lundgreen Abbie, Hines Lisa, Giuliano Anna, Baumgartner Kathy, Herrick Jennifer, Wolff Roger |
| Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. PloS one 2013 8 (4): e62023. Zhang Caiyun, Li Chao, Zhu Minhui, Zhang Qingzhou, Xie Zhenghua, Niu Gang, Song Xicheng, Jin Lei, Li Guojun, Zheng Honglia |
| Single nucleotide polymorphisms of matrix metallopeptidase 3 and risk of gliomas in a Chinese Han population. Molecular carcinogenesis 2012 Oct 51 Suppl 1 E1-10. Fan Weiwei, Zhou Keke, Hu Dezhi, Song Xiao, Zhao Yingjie, Chen Hongyan, Wei Qingyi, Chen Gong, Shi Jinlong, Du Guhong, Mao Ying, Lu Daru, Zhou Liang |
| The stromelysin-1 5A/5A genotype enhances colorectal cancer cell invasion in Iranian population. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2012 Oct 17 (10): 962-6. Motovali-Bashi Majid, Hojati Zohreh, Hajihoseiny Samaneh, Hemmati Sim |
| Association of MMP3-1171(5A>6A) polymorphism with lung cancer in Lebanon. Genetic testing and molecular biomarkers 2012 Aug 16 (8): 988-90. Fakhoury Hana M A, Noureddine Sara, Tamim Hani, Chmaisse Hania, Makki Raj |
| Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC cancer 2012 Mar 12 (1): 1. Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, Tardon A |
| Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 18 (1): 196-206. Azad Abul Kalam, Bairati Isabelle, Samson Elodie, Cheng Dangxiao, Mirshams Maryam, Qiu Xin, Savas Sevtap, Waldron John, Wang Changshu, Goldstein David, Xu Wei, Meyer Francois, Liu Geoffr |
| Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PloS one 2012 7 (2): e31251. Liu Dan, Guo Hong, Li Yafei, Xu Xueqing, Yang Kang, Bai Y |
| Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population. Molecular carcinogenesis 2011 Nov . Dey S, Stalin S, Gupta A, Saha D, Kesh K, Swarnakar S |
| Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer. International journal of colorectal disease 2011 Sep 26 (9): 1099-105. Liu Dan, Duan Wenyuan, Guo Hong, Xu Xueqing, Bai Y |
| Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Jun . Neuhausen SL, Brummel S, Ding YC, Steele L, Nathanson KL, Domchek SM, Rebbeck TR, Singer CF, Pfeiler G, Lynch HT, Garber JE, Couch FJ, Weitzel JN, Godwin AK, Narod SA, Ganz PA, Daly MB, Isaacs C, Olopade OI, Tomlinson GE, Rubinstein WS, Tung N, Blum JL, Gillen DL |
| Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS genetics 2010 Jul 6 (7): e1001016. Johnatty Sharon E, Beesley Jonathan, Chen Xiaoqing, Macgregor Stuart, Duffy David L, Spurdle Amanda B, deFazio Anna, Gava Natalie, Webb Penelope M, Rossing Mary Anne, Doherty Jennifer Anne, Goodman Marc T, Lurie Galina, Thompson Pamela J, Wilkens Lynne R, Ness Roberta B, Moysich Kirsten B, Chang-Claude Jenny, Wang-Gohrke Shan, Cramer Daniel W, Terry Kathryn L, Hankinson Susan E, Tworoger Shelley S, Garcia-Closas Montserrat, Yang Hannah, Lissowska Jolanta, Chanock Stephen J, Pharoah Paul D, Song Honglin, Whitemore Alice S, Pearce Celeste L, Stram Daniel O, Wu Anna H, Pike Malcolm C, Gayther Simon A, Ramus Susan J, Menon Usha, Gentry-Maharaj Aleksandra, Anton-Culver Hoda, Ziogas Argyrios, Hogdall Estrid, Kjaer Susanne K, Hogdall Claus, Berchuck Andrew, Schildkraut Joellen M, Iversen Edwin S, Moorman Patricia G, Phelan Catherine M, Sellers Thomas A, Cunningham Julie M, Vierkant Robert A, Rider David N, Goode Ellen L, Haviv Izhak, Chenevix-Trench Georgia, , , |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: